Table of Contents Global Molecular Diagnostics in Cancer Testing Market by Manufacturers, Regions, Type and Application, Forecast to 2023 1 Report Overview 1.1 Definition and Specification 1.2 Report Overview 1.2.1 Manufacturers Overview 1.2.2 Regions Overview 1.2.3 Type Overview 1.2.4 Application Overview 1.3 Industrial Chain 1.3.1 Molecular Diagnostics in Cancer Testing Overall Industrial Chain 1.3.2 Upstream 1.3.3 Downstream 1.4 Industry Situation 1.4.1 Industrial Policy 1.4.2 Product Preference 1.4.3 Economic/Political Environment 1.5 SWOT Analysis 2 Product Type Market 2.1 World Product Type Market Performance and Trend 2.1.1 World Market Performance 2.1.2 Different Type of Market Performance 2.2 North America Product Type Market Performance and Trend 2.2.1 North America Market Performance 2.2.2 Different Type of Market Performance 2.3 Europe Product Type Market Performance and Trend 2.3.1 Europe Market Performance 2.3.2 Different Type of Market Performance 2.4 Asia-Pacific Product Type Market Performance and Trend 2.4.1 Asia-Pacific Market Performance 2.4.2 Different Type of Market Performance 2.5 South America Product Type Market Performance and Trend 2.5.1 South America Market Performance 2.5.2 Different Type of Market Performance 2.6 Middle East and Africa Product Type Market Performance and Trend 2.6.1 Middle East and Africa Market Performance 2.6.2 Different Type of Market Performance 3 Product Application Market 3.1 World Product Application Market Performance and Trend 3.1.1 World Market Performance 3.1.2 Different Applications of Market Trend 3.2 North America Product Application Market Performance and Trend 3.2.1 North America Market Performance 3.2.2 Different Applications of Market Trend 3.3 Europe Product Application Market Performance and Trend 3.3.1 Europe Market Performance 3.3.2 Different Applications of Market Trend 3.4 Asia-Pacific Product Application Market Performance and Trend 3.4.1 Asia-Pacific Market Performance 3.4.2 Different Applications of Market Trend 3.5 South America Product Application Market Performance and Trend 3.5.1 South America Market Performance 3.5.2 Different Applications of Market Trend 3.6 Middle East and Africa Product Application Market Performance and Trend 3.6.1 Middle East and Africa Market Performance 3.6.2 Different Applications of Market Trend 4 Manufacturers Profiles/Analysis 4.1 Abbott Molecular Diagnostics 4.1.1 Abbott Molecular Diagnostics Profiles 4.1.2 Abbott Molecular Diagnostics Product Information 4.1.3 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Business Performance 4.1.4 Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.2 Accugenomics 4.2.1 Accugenomics Profiles 4.2.2 Accugenomics Product Information 4.2.3 Accugenomics Molecular Diagnostics in Cancer Testing Business Performance 4.2.4 Accugenomics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.3 Agendia 4.3.1 Agendia Profiles 4.3.2 Agendia Product Information 4.3.3 Agendia Molecular Diagnostics in Cancer Testing Business Performance 4.3.4 Agendia Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.4 Ambry Genetics 4.4.1 Ambry Genetics Profiles 4.4.2 Ambry Genetics Product Information 4.4.3 Ambry Genetics Molecular Diagnostics in Cancer Testing Business Performance 4.4.4 Ambry Genetics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.5 Biodesix 4.5.1 Biodesix Profiles 4.5.2 Biodesix Product Information 4.5.3 Biodesix Molecular Diagnostics in Cancer Testing Business Performance 4.5.4 Biodesix Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.6 bioMerieux 4.6.1 bioMerieux Profiles 4.6.2 bioMerieux Product Information 4.6.3 bioMerieux Molecular Diagnostics in Cancer Testing Business Performance 4.6.4 bioMerieux Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.7 bioTheranostics (AviaraDx) 4.7.1 bioTheranostics (AviaraDx) Profiles 4.7.2 bioTheranostics (AviaraDx) Product Information 4.7.3 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Business Performance 4.7.4 bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.8 Cancer Genetics 4.8.1 Cancer Genetics Profiles 4.8.2 Cancer Genetics Product Information 4.8.3 Cancer Genetics Molecular Diagnostics in Cancer Testing Business Performance 4.8.4 Cancer Genetics Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.9 Clarient, Inc. (GE Healthcare) 4.9.1 Clarient, Inc. (GE Healthcare) Profiles 4.9.2 Clarient, Inc. (GE Healthcare) Product Information 4.9.3 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Business Performance 4.9.4 Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.10 Counsyl 4.10.1 Counsyl Profiles 4.10.2 Counsyl Product Information 4.10.3 Counsyl Molecular Diagnostics in Cancer Testing Business Performance 4.10.4 Counsyl Molecular Diagnostics in Cancer Testing Business Development and Market Status 4.11 Flatiron Health 4.12 Epigenomics 4.13 Agendia 4.14 Ambry Genetics 4.15 Biodesix 5 Market Performance for Manufacturers 5.1 Global Molecular Diagnostics in Cancer Testing Sales (K Units) and Market Share by Manufacturers 2013-2018 5.2 Global Molecular Diagnostics in Cancer Testing Revenue (M USD) and Market Share by Manufacturers 2013-2018 5.3 Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 5.4 Global Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 5.5 Market Concentration 6 Regions Market Performance for Manufacturers 6.1 North America Market Performance for Manufacturers 6.1.1 North America Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.1.2 North America Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.1.3 North America Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.1.4 North America Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.1.5 Market Concentration 6.2 Europe Market Performance for Manufacturers 6.2.1 Europe Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.2.2 Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.2.3 Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.2.4 Europe Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.2.5 Market Concentration 6.3 Asia-Pacific Market Performance for Manufacturers 6.3.1 Asia-Pacific Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.3.2 Asia-Pacific Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.3.3 Asia-Pacific Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.3.4 Asia-Pacific Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.3.5 Market Concentration 6.4 South America Market Performance for Manufacturers 6.4.1 South America Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.4.2 South America Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.4.3 South America Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.4.4 South America Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.4.5 Market Concentration 6.5 Middle East and Africa Market Performance for Manufacturers 6.5.1 Middle East and Africa Molecular Diagnostics in Cancer Testing Sales (K Units) and Share of Manufacturers 2013-2018 6.5.2 Middle East and Africa Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share of Manufacturers 2013-2018 6.5.3 Middle East and Africa Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 6.5.4 Middle East and Africa Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 6.5.5 Market Concentration 7 World Market Performance Point 7.1 World Molecular Diagnostics in Cancer Testing Sales (K Units) and Share by Regions and Countries 2013-2018 7.1.1 World Molecular Diagnostics in Cancer Testing Sales (K Units) and Share by Regions 2013-2018 7.1.2 Regional Sales (K Units) and Share by Countries 2013-2018 7.1.2.1 Asia-Pacific Molecular Diagnostics in Cancer Testing Sales (K Units) and Share by Countries 2013-2018 7.1.2.2 North America Molecular Diagnostics in Cancer Testing Sales (K Units) and Share by Countries 2013-2018 7.1.2.3 Europe Molecular Diagnostics in Cancer Testing Sales (K Units) and Share by Countries 2013-2018 7.1.2.4 South America Molecular Diagnostics in Cancer Testing Sales (K Units) and Share by Countries 2013-2018 7.1.2.5 Middle East and Africa Molecular Diagnostics in Cancer Testing Sales (K Units) and Share by Countries 2013-2018 7.2 World Revenue (M USD) and Share by Regions and Countries 2013-2018 7.2.1 World Revenue (M USD) and Share by Regions 2013-2018 7.2.2 Regional Revenue (M USD) and Share by Countries 2013-2018 7.2.2.1 Asia-Pacific Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share by Countries 2013-2018 7.2.2.2 North America Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share by Countries 2013-2018 7.2.2.3 Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share by Countries 2013-2018 7.2.2.4 South America Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share by Countries 2013-2018 7.2.2.5 Middle East and Africa Molecular Diagnostics in Cancer Testing Revenue (M USD) and Share by Countries 2013-2018 7.3 World Price (USD/Unit) by Regions and Countries 2013-2018 7.3.1 World Price (USD/Unit) by Regions 2013-2018 7.3.2 Regional Price (USD/Unit) by Countries 2013-2018 7.3.2.1 Asia-Pacific Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Countries 2013-2018 7.3.2.2 North America Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Countries 2013-2018 7.3.2.3 Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Countries 2013-2018 7.3.2.4 South America Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Countries 2013-2018 7.3.2.5 Middle East and Africa Molecular Diagnostics in Cancer Testing Price (USD/Unit) by Countries 2013-2018 7.4 World Gross Margin by Regions and Countries 2013-2018 7.4.1 World Gross Margin by Regions 2013-2018 7.4.2 Regional Gross Margin and Share by Countries 2013-2018 7.4.2.1 Asia-Pacific Molecular Diagnostics in Cancer Testing Gross Margin and Share by Countries 2013-2018 7.4.2.2 North America Molecular Diagnostics in Cancer Testing Gross Margin and Share by Countries 2013-2018 7.4.2.3 Europe Molecular Diagnostics in Cancer Testing Gross Margin and Share by Countries 2013-2018 7.4.2.4 South America Molecular Diagnostics in Cancer Testing Gross Margin and Share by Countries 2013-2018 7.4.2.5 Middle East and Africa Molecular Diagnostics in Cancer Testing Gross Margin and Share by Countries 2013-2018 8 Development Trend for Regions and Countries (Sales Point) 8.1 World Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2 Asia-Pacific Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2.1 China Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2.2 Japan Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2.3 Korea Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2.4 India Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.2.5 Southeast Asia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.3 North America Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.3.1 United States Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.3.2 Canada Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.3.3 Mexico Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4 Europe Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4.1 Germany Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4.2 UK Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4.3 France Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4.4 Russia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.4.5 Italy Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.5 South America Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.5.1 Brazil Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.5.2 Argentina Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.5.3 Columbia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6 Middle East and Africa Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6.1 Saudi Arabia Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6.2 UAE Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6.3 Egypt Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6.4 Nigeria Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 8.6.5 South Africa Sales (K Units), Revenue (M USD) and Growth Rate 2013-2018 9 Upstream Source, Technology and Cost 9.1 Upstream Source 9.2 Technology 9.3 Cost 10 Channel Analysis 10.1 Market Channel 10.2 Distributors 11 Consumer Analysis 11.1 Application 1 Industry 11.2 Application 2 Industry 12 Market Forecast 2019-2024 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2019-2024 12.1.1 Global Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Market Share by Regions 2019-2024 12.1.2 Global Molecular Diagnostics in Cancer Testing Sales (K Units) and Growth Rate 2019-2024 12.1.3 Asia-Pacific Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.4 Asia-Pacific Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.5 Europe Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.6 South America Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.1.7 Middle East and Africa Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.2 Sales (K Units), Revenue (M USD) by Types 2019-2024 12.2.1 Overall Market Performance 12.2.2 Type I Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.2.3 Type II Sales (K Units), Revenue (M USD) and Growth Rate 2019-2024 12.3 Sales by Application 2019-2024 12.3.1 Overall Market Performance 12.3.2 Application 1 Sales and and Growth Rate 2019-2024 12.3.3 Application 2 Sales and and Growth Rate 2019-2024 12.4 Price (USD/Unit) and Gross Profit 12.4.1 Global Molecular Diagnostics in Cancer Testing Price (USD/Unit) Trend 2019-2024 12.4.2 Global Molecular Diagnostics in Cancer Testing Gross Profit Trend 2019-2024 13 Conclusion

List of Tables and Figures Figure Product Picture of Molecular Diagnostics in Cancer Testing Table Product Specifications of Molecular Diagnostics in Cancer Testing Table Manufacturers List in the Report Table Manufacturers Market Share 2013-2018 Table Regions Overview in the Report Table Product Type and Standard Table Type Overview Table Product Application and Standard Table Application Overview in the Report Figure Industry Chain Structure of Molecular Diagnostics in Cancer Testing Table Industry News List of Molecular Diagnostics in Cancer Testing Figure New Project SWOT Analysis of Molecular Diagnostics in Cancer Testing Table World 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Type Figure World Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2013 Figure World Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2018 Table World 2013-2018 Molecular Diagnostics in Cancer TestingRevenue (M USD) by Type Figure World Molecular Diagnostics in Cancer TestingRevenue Market Share (%) by Type in 2013 Figure World Molecular Diagnostics in Cancer TestingRevenue Market Share (%) by Type in 2018 Table World Type I Sales (K Units) and Growth Rate Figure World Type I Sales (K Units) and Growth Rate Table World Type I Revenue (M USD) and Growth Rate Figure World Type I Revenue (M USD) and Growth Rate Table World Type II Sales (K Units) and Growth Rate Figure World Type II Sales (K Units) and Growth Rate Table World Type II Revenue (M USD) and Growth Rate Figure World Type II Revenue (M USD) and Growth Rate Table North America 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Type Figure North America Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2013 Figure North America Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2018 Table North America 2013-2018 Molecular Diagnostics in Cancer TestingRevenue (M USD) by Type Figure North America Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Type in 2013 Figure North America Molecular Diagnostics in Cancer Testing Revenue Market Share (%) by Type in 2018 Table North America Type I Sales (K Units) and Growth Rate Figure North America Type I Sales (K Units) and Growth Rate Table North America Type I Revenue (M USD) and Growth Rate Figure North America Type I Revenue (M USD) and Growth Rate Table North America Type II Sales (K Units) and Growth Rate Figure North America Type II Sales (K Units) and Growth Rate Table North America Type II Revenue (M USD) and Growth Rate Figure North America Type II Revenue (M USD) and Growth Rate Table Europe 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Type Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2018 Table Europe 2013-2018 Molecular Diagnostics in Cancer TestingRevenue (M USD) by Type Figure Europe Molecular Diagnostics in Cancer TestingRevenue Market Share (%) by Type in 2013 Figure Europe Molecular Diagnostics in Cancer TestingRevenue Market Share (%) by Type in 2018 Table Europe Type I Sales (K Units) and Growth Rate Figure Europe Type I Sales (K Units) and Growth Rate Table Europe Type I Revenue (M USD) and Growth Rate Figure Europe Type I Revenue (M USD) and Growth Rate Table Europe Type II Sales (K Units) and Growth Rate Figure Europe Type II Sales (K Units) and Growth Rate Table Europe Type II Revenue (M USD) and Growth Rate Figure Europe Type II Revenue (M USD) and Growth Rate Table Asia-Pacific 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Type Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2013 Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2018 Table Asia-Pacific 2013-2018 Molecular Diagnostics in Cancer TestingRevenue (M USD) by Type Figure Asia-Pacific Molecular Diagnostics in Cancer TestingRevenue Market Share (%) by Type in 2013 Figure Asia-Pacific Molecular Diagnostics in Cancer TestingRevenue Market Share (%) by Type in 2018 Table Asia-Pacific Type I Sales (K Units) and Growth Rate Figure Asia-Pacific Type I Sales (K Units) and Growth Rate Table Asia-Pacific Type I Revenue (M USD) and Growth Rate Figure Asia-Pacific Type I Revenue (M USD) and Growth Rate Table Asia-Pacific Type II Sales (K Units) and Growth Rate Figure Asia-Pacific Type II Sales (K Units) and Growth Rate Table Asia-Pacific Type II Revenue (M USD) and Growth Rate Figure Asia-Pacific Type II Revenue (M USD) and Growth Rate Table South America 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Type Figure South America Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2013 Figure South America Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2018 Table South America 2013-2018 Molecular Diagnostics in Cancer TestingRevenue (M USD) by Type Figure South America Molecular Diagnostics in Cancer TestingRevenue Market Share (%) by Type in 2013 Figure South America Molecular Diagnostics in Cancer TestingRevenue Market Share (%) by Type in 2018 Table South America Type I Sales (K Units) and Growth Rate Figure South America Type I Sales (K Units) and Growth Rate Table South America Type I Revenue (M USD) and Growth Rate Figure South America Type I Revenue (M USD) and Growth Rate Table South America Type II Sales (K Units) and Growth Rate Figure South America Type II Sales (K Units) and Growth Rate Table South America Type II Revenue (M USD) and Growth Rate Figure South America Type II Revenue (M USD) and Growth Rate Table Middle East and Africa 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Type Figure Middle East and Africa Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2013 Figure Middle East and Africa Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Type in 2018 Table Middle East and Africa 2013-2018 Molecular Diagnostics in Cancer TestingRevenue (M USD) by Type Figure Middle East and Africa Molecular Diagnostics in Cancer TestingRevenue Market Share (%) by Type in 2013 Figure Middle East and Africa Molecular Diagnostics in Cancer TestingRevenue Market Share (%) by Type in 2018 Table Middle East and Africa Type I Sales (K Units) and Growth Rate Figure Middle East and Africa Type I Sales (K Units) and Growth Rate Table Middle East and Africa Type I Revenue (M USD) and Growth Rate Figure Middle East and Africa Type I Revenue (M USD) and Growth Rate Table Middle East and Africa Type II Sales (K Units) and Growth Rate Figure Middle East and Africa Type II Sales (K Units) and Growth Rate Table Middle East and Africa Type II Revenue (M USD) and Growth Rate Figure Middle East and Africa Type II Revenue (M USD) and Growth Rate Table World 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Application Figure World Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2013 Figure World Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2018 Table World Application 1 Sales (K Units) and Growth Rate Figure World Application 1 Sales (K Units) and Growth Rate Table World Application 2 Sales (K Units) and Growth Rate Figure World Application 2 Sales (K Units) and Growth Rate Table North America 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Application Figure North America Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2013 Figure North America Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2018 Table North America Application 1 Sales (K Units) and Growth Rate Figure North America Application 1 Sales (K Units) and Growth Rate Table North America Application 2 Sales (K Units) and Growth Rate Figure North America Application 2 Sales (K Units) and Growth Rate Table Europe 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Application Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2018 Table Europe Application 1 Sales (K Units) and Growth Rate Figure Europe Application 1 Sales (K Units) and Growth Rate Table Europe Application 2 Sales (K Units) and Growth Rate Figure Europe Application 2 Sales (K Units) and Growth Rate Table Asia-Pacific 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Application Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2013 Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2018 Table Asia-Pacific Application 1 Sales (K Units) and Growth Rate Figure Asia-Pacific Application 1 Sales (K Units) and Growth Rate Table Asia-Pacific Application 2 Sales (K Units) and Growth Rate Figure Asia-Pacific Application 2 Sales (K Units) and Growth Rate Table South America 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Application Figure South America Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2013 Figure South America Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2018 Table South America Application 1 Sales (K Units) and Growth Rate Figure South America Application 1 Sales (K Units) and Growth Rate Table South America Application 2 Sales (K Units) and Growth Rate Figure South America Application 2 Sales (K Units) and Growth Rate Table Middle East and Africa 2013-2018 Molecular Diagnostics in Cancer Testing Sales (K Units) by Application Figure Middle East and Africa Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2013 Figure Middle East and Africa Molecular Diagnostics in Cancer Testing Sales Market Share (%) by Application in 2018 Table Middle East and Africa Application 1 Sales (K Units) and Growth Rate Figure Middle East and Africa Application 1 Sales (K Units) and Growth Rate Table Middle East and Africa Application 2 Sales (K Units) and Growth Rate Figure Middle East and Africa Application 2 Sales (K Units) and Growth Rate Table Abbott Molecular Diagnostics Profiles Table Abbott Molecular Diagnostics Product Information Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Abbott Molecular Diagnostics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Accugenomics Profiles Table Accugenomics Product Information Table Accugenomics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Accugenomics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Accugenomics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Agendia Profiles Table Agendia Product Information Table Agendia Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Agendia Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Agendia Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Ambry Genetics Profiles Table Ambry Genetics Product Information Table Ambry Genetics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Ambry Genetics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Ambry Genetics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Biodesix Profiles Table Biodesix Product Information Table Biodesix Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Biodesix Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Biodesix Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table bioMerieux Profiles Table bioMerieux Product Information Table bioMerieux Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table bioMerieux Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table bioMerieux Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table bioTheranostics (AviaraDx) Profiles Table bioTheranostics (AviaraDx) Product Information Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table bioTheranostics (AviaraDx) Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Cancer Genetics Profiles Table Cancer Genetics Product Information Table Cancer Genetics Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Cancer Genetics Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Cancer Genetics Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Clarient, Inc. (GE Healthcare) Profiles Table Clarient, Inc. (GE Healthcare) Product Information Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Clarient, Inc. (GE Healthcare) Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table Counsyl Profiles Table Counsyl Product Information Table Counsyl Molecular Diagnostics in Cancer Testing Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2013-2018 Table Counsyl Molecular Diagnostics in Cancer Testing Sales Change 2013-2018 Table Counsyl Molecular Diagnostics in Cancer Testing Market Status Change 2013-2018 Table World Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table World Molecular Diagnostics in Cancer Testing Sales Share of Manufacturers 2013-2018 Figure World Molecular Diagnostics in Cancer Testing Sales Share in 2013 Figure World Molecular Diagnostics in Cancer Testing Sales Share in 2018 Table World Revenue (M USD) of Manufacturers 2013-2018 Table World Revenue Share of Manufacturers 2013-2018 Figure World Revenue Share in 2013 Figure World Revenue Share in 2018 Table World Price (USD/Unit) of Manufacturers 2013-2018 Figure World Price (USD/Unit) of Manufacturers in 2013 Figure World Price (USD/Unit) of Manufacturers in 2018 Table World Gross Margin of Manufacturers 2013-2018 Figure World Gross Margin of Manufacturers in 2013 Figure World Gross Margin in 2018 Figure World Market Concentration 2013-2018 Table Top 3 Sales Share 2013-2018 Table Top 5 Sales Share 2013-2018 Table Top 8 Sales Share 2013-2018 Table Asia-Pacific Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Asia-Pacific Molecular Diagnostics in Cancer Testing Sales Share of Manufacturers 2013-2018 Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Sales Share in 2013 Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Sales Share in 2018 Table Asia-Pacific Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Asia-Pacific Molecular Diagnostics in Cancer Testing Revenue Share of Manufacturers 2013-2018 Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Revenue Share in 2013 Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Revenue Share in 2018 Table Asia-Pacific Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Asia-Pacific Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Asia-Pacific Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Asia-Pacific Market Concentration 2013-2018 Table Top 3 Sales Share 2013-2018 Table Top 5 Sales Share 2013-2018 Table Top 8 Sales Share 2013-2018 Table North America Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table North America Molecular Diagnostics in Cancer Testing Sales Share of Manufacturers 2013-2018 Figure North America Molecular Diagnostics in Cancer Testing Sales Share in 2013 Figure North America Molecular Diagnostics in Cancer Testing Sales Share in 2018 Table North America Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table North America Molecular Diagnostics in Cancer Testing Revenue Share of Manufacturers 2013-2018 Figure North America Molecular Diagnostics in Cancer Testing Revenue Share in 2013 Figure North America Molecular Diagnostics in Cancer Testing Revenue Share in 2018 Table North America Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure North America Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure North America Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table North America Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure North America Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure North America Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure North America Market Concentration 2013-2018 Table Top 3 Sales Share 2013-2018 Table Top 5 Sales Share 2013-2018 Table Top 8 Sales Share 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Sales Share of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Sales Share in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Sales Share in 2018 Table Europe Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table Europe Molecular Diagnostics in Cancer Testing Revenue Share of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Revenue Share in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Revenue Share in 2018 Table Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Price (USD/Unit) of Manufacturers in 2018 Table Europe Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers 2013-2018 Figure Europe Molecular Diagnostics in Cancer Testing Gross Margin of Manufacturers in 2013 Figure Europe Molecular Diagnostics in Cancer Testing Gross Margin in 2018 Figure Europe Market Concentration 2013-2018 Table Top 3 Sales Share 2013-2018 Table Top 5 Sales Share 2013-2018 Table Top 8 Sales Share 2013-2018 Table South America Molecular Diagnostics in Cancer Testing Sales (K Units) of Manufacturers 2013-2018 Table South America Molecular Diagnostics in Cancer Testing Sales Share of Manufacturers 2013-2018 Figure South America Molecular Diagnostics in Cancer Testing Sales Share in 2013 Figure South America Molecular Diagnostics in Cancer Testing Sales Share in 2018 Table South America Molecular Diagnostics in Cancer Testing Revenue (M USD) of Manufacturers 2013-2018 Table South America Molecular Diagnostics in Cancer Testing Revenue Share of Manufacturers 2013-2018

Abbott Molecular Diagnostics Accugenomics Agendia Ambry Genetics Biodesix bioMerieux bioTheranostics (AviaraDx) Cancer Genetics Clarient, Inc. (GE Healthcare) Counsyl Flatiron Health Epigenomics Exact Sciences Corporation Exiqon Genomic Health